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ASSOCIATIONS BETWEEN ABNORMAL INFRAPATELLAR FAT PAD
QUALITY AND KNEE OSTEOARTHRITIC CHANGES IN OLDER ADULTS:
A COHORT STUDY
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Purpose: There have been no clinical and epidemiological studies
reporting the association between infrapatellar fat pad abnormal
changes and knee osteoarthritis measures so the role of infrapatellar fat
pad quality in knee osteoarthritis is unclear. Aim of this study was to
determine the cross-sectional and longitudinal associations between
abnormal infrapatellar fat pad quality and knee osteoarthritic changes
in older adults.
Methods: A total of 971 subjects (mean 62.4 years, 50.1% female)
selected randomly from local community were studied. Radiographic
knee osteophyte and joint space narrowing (JSN) were assessed using
the OARSI atlas. T1- or T2-weighted fat suppressed magnetic resonance
imaging (MRI) was utilized to assess infrapatellar fat pad quality (signal
intensity change and soft tissue thickening), cartilage volume, cartilage
defects, and bone marrow lesions (BMLs). Knee pain was assessed by
self-administered Western Ontario McMaster Osteoarthritis Index
(WOMAC) questionnaire.
Results: In cross-sectional analyses, both signal intensity change and
soft tissue thickening were signiﬁcantly and positively associated with
knee osteophytes, cartilage defects, bonemarrow lesions, and knee pain
and stiffness, while negatively associated with patellar cartilage volume
after adjustment for potential confounders. Soft tissue thickening was
also signiﬁcantly and positively associated with knee joint space nar-
rowing and dysfunction. Longitudinally, signal intensity change was
signiﬁcantly and positively associatedwith increases in cartilage defects
[OR: 1.46, 95% CI: 1.13–1.90 (medial tibiofemoral); OR: 1.45, 95% CI:
1.12–1.87 (lateral tibiofemoral)], bone marrow lesions [OR: 1.44, 95% CI:
1.05–1.99 (medial tibiofemoral); OR: 1.77, 95% CI: 1.31–2.40 (lateral
tibiofemoral)], and keen pain when going up/down stairs (OR: 1.27, 95%
CI: 1.01–1.59), whereas negatively associated with per annum change in
lateral tibial cartilage volume (b: 15.4 mm3, 95% CI: 29.2, 1.7).
Consistently, soft tissue thickening was signiﬁcantly and positively
associated with increases in cartilage defects [OR: 1.56, 95% CI: 1.18–
2.06 (medial tibiofemoral); OR: 1.50, 95% CI: 1.14–1.98 (lateral tibiofe-
moral)], bone marrow lesions [OR: 1.82, 95% CI: 1.29–2.58 (medial
tibiofemoral); OR: 1.65, 95% CI: 1.19–2.27 (lateral tibiofemoral)], keen
painwhenwalking on ﬂat surface (OR: 1.57, 95% CI: 1.14–2.16), going up/
down stairs (OR: 1.56, 95% CI: 1.19–2.04), standing (OR: 1.48, 95% CI:
1.08–2.03), and knee dysfunction (OR: 1.27, 95% CI: 1.00–1.61), but
negatively associated with per annum change in lateral tibial cartilage
volume (b: 16.8 mm3, 95% CI: 31.8, 1.8).
Conclusions: Signal intensity change and soft tissue thickening within
infrapatellar fat pad were associated with clinical and structural
abnormalities of knee joint cross-sectionally and over 2.6 years in older
adults. These suggest that abnormal infrapatellar fat pad quality may
have a detrimental role in the development or progression of knee
osteoarthritis.
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Purpose: Differences in the incidence of several major early post-
operative complications have been reported following hip and knee
arthroplasty procedures for osteoarthritis (OA). However, given the
postulated different pathogenesis and comorbidities associated with
OA of these joints, the relative contributions of these comorbidities to
the observed complications, as compared to the surgical procedureitself, are unclear. Thus, the purpose of the present study was to
investigate whether comorbidities known to be associated with end-
stage knee OA explained differences in the risk of major complications
within 30 days of arthroplasty surgery between patients undergoing
surgery for knee and hip OA.
Methods: All patients who underwent primary total knee (TKA) or hip
arthroplasty (THA) for a diagnosis of OAwere extracted from the 2010 to
2012 American College of Surgeons National Surgical Quality
Improvement Project databases. Combined, these databases include
preoperative risk factor and 30 day postoperative morbidity data from
374 clinical sites in North America, abstracted by trained reviewers. The
study cohort encompassed 54,022 cases, including 33,906 of knee OA
and 20,116 of hip OA. Patient data extracted included age, gender, and
body mass index (BMI) stratiﬁed by World Health Organization (WHO)
class. In a previous study, the following comorbidities were identiﬁed to
be independently associated with end-stage knee OA: hypertension
requiring medication, diabetes, and higher grade of obesity. Addition-
ally, other variables known to be associated with the risk of one or more
complications of interest were extracted, including smoking status
within one year of surgery, chronic systemic steroid use within 30 days
of surgery, and length of surgery. The speciﬁc major complications
evaluated were any surgical site infection (SSI), pulmonary embolism
(PE), myocardial infarction (MI) and deep vein thrombosis (DVT).
Descriptive statistics were obtained. Logistic regression analyses were
performed to assess the odds of developing any major complication, as
well each major complication individually, between patients with end-
stage knee and hip OA undergoing surgery adjusting for demographics
and identiﬁed comorbidities.
Results: Signiﬁcantly greater odds of developing a major complication
were observed in patients with knee OA as compared to those with hip
OA when controlled for age and gender alone (OR: 1.22; 95%CI [1.08–
1.37]). However, after controlling for associated comorbidities and other
risk factors, knee arthroplasty itself was not associated with sig-
niﬁcantly different odds of experiencing a major complication (1.13;
95% CI [0.99–1.27]). Increasing obesity was associated with increased
odds of SSI (grade III vs normal OR 2.40; 95% CI [1.66–3.47]) and PE (OR
2.51; 95%CI [1.32–4.79]). Diabetes was associated with increased odds
of SSI (OR 1.46; 95%CI [1.18–1.80]) and MI (OR 1.98; 95% CI [1.36–2.88]).
Hypertensionwas associated with increased odds of MI (OR 2.33; 95% CI
[1.44–3.76]). None of the studied comorbidities were found to inde-
pendently predict differences in the odds of DVT.
Conclusions: The results of the present study suggest that the relative
probabilities of developing early post-operative major complications
following knee and hip arthroplasty for OA are signiﬁcantly inﬂuenced
by patients’ comorbidities. Given the increased prevalence of important
predictors such as obesity, diabetes and hypertension among patients
with end-stage knee OA, some of the probability of developing com-
plications following knee arthroplasty may be incorrectly attributed to
the procedure itself, rather than to differences in patient characteristics
when compared to those undergoing hip arthroplasty.
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THE RELATIONSHIP BETWEEN PRE-OPERATIVE ‘TIMED GET UP AND
GO’ AND LENGTH OF STAY IN PRIMARY ELECTIVE HIP AND KNEE
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Purpose: To test whether a relationship exists between length of stay
(LoS) and the ‘timed get up and go’ test (TUG), an easily administered
and validated functional measure, within the Clinical Outcomes in
Arthroplasty Study (COASt) cohort.
The number of patients undergoing lower limb arthroplasty is con-
tinuing to rise. The increasing number of elective surgery patients will
demand an increasing share of hospital beds. Clinical tools that could
predict hospital LoS may help identify modiﬁable risk factors that could
inﬂuence patient outcomes as well as costs.
Methods: Patients presenting with symptomatic end-stage osteo-
arthritis causing pain or reduced function who elected for surgery were
considered for this study. Participants included 534 elective primary
lower limb arthroplasty patients; 236 total hip (THR), 161 total knee
(TKR) and 137 uni-compartmental knee replacement (UKR) attending
